Should we move beyond VEGF inhibition in metastatic colorectal cancer? Lessons from early phase clinical trials

Sukeshi R. Patel, Anand B. Karnad, Norma S. Ketchum, Brad H. Pollock, John Sarantopoulos, Steven Weitman, Devalingam Mahalingam*

*Corresponding author for this work

Research output: Contribution to journal › Article › peer-review

8 Scopus citations

Fingerprint

Dive into the research topics of 'Should we move beyond VEGF inhibition in metastatic colorectal cancer? Lessons from early phase clinical trials'. Together they form a unique fingerprint.

Keyphrases

Pharmacology, Toxicology and Pharmaceutical Science